出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年3月
動物寄生虫駆除剤市場 : タイプ (外部寄生虫駆除剤、内部寄生虫駆除剤、エンドクトサイド剤)、動物の種類 (犬、猫、馬、牛、豚、家禽、ヤギ)、エンドユーザー (獣医病院、畜産場、在宅医療環境) – 2027年までの世界予測
Animal Parasiticides Market by Type (Ectoparasiticides, Endoparasiticides, Endectocides), Animal Type (Dogs, Cats, Horses, Cattle, Pigs, Poultry, Goats), End User (Veterinary Hospitals, Animal farms, Home Care Settings) – Global Forecast to 2027
| ページ数 | 285 |
| 図表数 | 322 |
| 種別 | 英文調査報告書 |
| 価格 |
The market for animal parasiticides is anticipated to grow from USD 10.6 billion in 2022 to USD 14.1 billion in 2027, at a CAGR of 5.8% over the forecast period. The market for animal parasiticides is expanding as a result of factors like the rising demand for food products made from animals, growing private player investments, laws aimed at preventing the spread of animal diseases, and rising costs for animal health care. During the projected period, regulations on the use of parasiticides on animals used for food production and a move toward vegetarianism will likely hamper the growth of this market.
“ectoparasiticides segment was dominated by the highest share in animal parasiticides market”
The animal parasiticides market is divided into endoparasiticides, ectoparasiticides, and endectocides based on type. The ectoparasiticides segment accounted for the highest share of the global animal parasiticides market in 2021. The high adoption of ectoparasiticides relative to other products is responsible for the huge proportion of this market. The rise in ownership of animals and the number of companion animals in developed nations are additional factors that are anticipated to promote market expansion throughout the projected period.
“Companion animals segment is accounted for highest market share in the forecast period.”
The market for animal parasiticides is divided into divisions for companion animals and livestock animals based on the animal type. The companion animals was the largest segment of the global market for animal parasiticides in 2021. Companion animals accounted for the largest share of the global animal parasiticides market in 2021. The significant market share of this sector is largely due to the rising costs of keeping pets and the rise in the number of people who own companion animals in developed countries.
“Veterinary clinics & hospitals segment is expected to witness the fastest growth in the forecast period.”
Animal farms, veterinary clinics & hospitals, and home care settings comprise the end-user segments of the market for animal parasiticides. The fastest growing market for animal parasiticides in 2021 was held by veterinary clinics and hospitals. The increased use of animal parasiticides in medical settings, the rise in parasitic illnesses, and the rising concern over animal health in developing nations are all factors that contribute to the fastest growth of this segment.
“Latin America is expected to witness the fastest growth in the forecast period.”
In the forecast period, Latin America in the animal parasiticides market will have the fastest rising regional growth. Rising numbers of companion and food-producing animals, as well as the region’s rising demand for food items generated from animals, are the main factors driving market growth. Several countries in Latin America are significant suppliers of beef to the global market. China has been recognized as the primary market for Brazilian beef exports, despite an increase in volume and overall value over the previous year. In the upcoming years, it is anticipated that a rise in beef exports from Latin American nations would support a rise in the market for animal parasiticides in this area.
Following is a list of the major players (supply-side) in the animal parasiticides market that this study refers to:
By Company Type: Tier 1- 34%, Tier 2- 46%, and Tier 3- 20%
By Designation: C-level- 35%, Director Level—25%, and Others- 40%
By Region: North America-30%, Europe-45%, Asia Pacific-20%, Latin America- 3%, and Middle
East and Africa-2%
Several of the major companies in the market for animal parasiticides include Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Ceva Santé Animale (France), Vetoquinol S.A. (France), PetIQ, Inc. (US), Norbrook (Ireland), and Bimeda Animal Health (Ireland).
Research Coverage:
The market study analyzes the main market segments for animal parasiticides. The objective of this study is to estimate the market’s size and growth potential across several categories according to kind, animal type, end user, and region. The report also provides a thorough competition analysis of the major market participants, together with company profiles, major insights regarding their product and service offerings, recent advancements, and key market strategies.
Key Benefits of Buying the Report:
The study provides data regarding the animal parasiticides market’s closest approximations and its segments, which will benefit market leaders and new entrants. This study will assist stakeholders in comprehending the competitive environment, obtaining insights to better position of their businesses, and developing appropriate go-to-market strategies. The research will also assist stakeholders in obtaining insights into the market’s pulse and learning about its major drivers, inhibitors, opportunities, and problems.
The report provides insights on the following pointers:
Analysis of key drivers (Rising demand for animal-derived food products, Growing prevalence of animal diseases, Regulations for preventing spread of animal diseases), restraints (Regulations restricting use of parasiticides for food-producing animals), opportunities (Lucrative growth opportunities in emerging markets), and challenges (Stringent regulatory approval process for drugs) influencing the growth of the Animal parasiticide market.
Product Development/innovation:
Comprehensive details on new technologies, R&D initiatives, and product and service launches for animal parasiticides market
Market Development:
Comprehensive data on attractive markets, and the research analyzes the global animal parasiticides market.
Market Diversification:
Detailed information on emerging products and services, unexplored regions, current trends, and investments in the animal parasiticide market.
Competitive Assessment:
Comprehensive analysis of market shares, growth plans, and service offerings of major companies operating in the animal parasiticide market like Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Merck & Co., Inc. (US), Boehringer Ingelheim GmbH (Germany), Ceva Santé Animale (France), Vetoquinol S.A. (France), PetIQ, Inc. (US), Norbrook (Ireland), and Bimeda Animal Health (Ireland).
目次
1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS AND EXCLUSIONS 35
1.3 MARKET SCOPE 36
1.3.1 MARKETS COVERED 36
FIGURE 1 ANIMAL PARASITICIDES MARKET SEGMENTATION 36
FIGURE 2 ANIMAL PARASITICIDES MARKET, BY REGION 37
1.3.2 YEARS CONSIDERED 37
1.4 CURRENCY 38
1.5 STAKEHOLDERS 38
1.6 SUMMARY OF CHANGES 39
1.6.1 RECESSION IMPACT 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH APPROACH 40
FIGURE 3 RESEARCH DESIGN 40
2.1.1 SECONDARY DATA 41
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY DATA 43
FIGURE 4 PRIMARY SOURCES 43
2.1.2.1 Key data from primary sources 44
2.1.2.2 Key industry insights 45
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 45
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 46
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY END USER, DESIGNATION, AND REGION 46
2.2 MARKET SIZE ESTIMATION 47
FIGURE 8 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 47
FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION: ZOETIS INC. 47
FIGURE 10 SUPPLY-SIDE ANALYSIS: ANIMAL PARASITICIDES MARKET (2021) 48
FIGURE 11 COUNTRY-LEVEL ANALYSIS OF ANIMAL PARASITICIDES MARKET 48
FIGURE 12 BOTTOM-UP APPROACH 49
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN ANIMAL PARASITICIDES MARKET (2022–2027): IMPACT ON MARKET GROWTH AND CAGR 50
FIGURE 14 CAGR PROJECTIONS 51
FIGURE 15 TOP-DOWN APPROACH 51
2.3 LIMITATIONS 52
2.3.1 METHODOLOGY-RELATED LIMITATIONS 52
2.3.2 MARKET BREAKDOWN AND DATA TRIANGULATION 53
FIGURE 16 MARKET DATA TRIANGULATION METHODOLOGY 53
2.4 MARKET SHARE ANALYSIS 54
2.5 ASSUMPTIONS 54
2.6 RISK ASSESSMENT/LIMITATIONS 55
2.7 IMPACT OF RECESSION 55
3 EXECUTIVE SUMMARY 56
FIGURE 17 ANIMAL PARASITICIDES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 56
FIGURE 18 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2022 VS. 2027 (USD MILLION) 57
FIGURE 19 ANIMAL PARASITICIDES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 57
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF ANIMAL PARASITICIDES MARKET 58
4 PREMIUM INSIGHTS 59
4.1 ANIMAL PARASITICIDES MARKET OVERVIEW 59
FIGURE 21 GROWING PREVALENCE OF ANIMAL DISEASES AND RISING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO DRIVE MARKET 59
4.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE AND COUNTRY (2021) 60
FIGURE 22 ECTOPARASITICIDES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC ANIMAL PARASITICIDES MARKET IN 2021 60
4.3 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
FIGURE 23 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 61
4.4 ANIMAL PARASITICIDES MARKET: REGIONAL MIX 62
FIGURE 24 NORTH AMERICA TO CONTINUE TO DOMINATE ANIMAL PARASITICIDES MARKET IN 2027 62
4.5 ANIMAL PARASITICIDES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 62
FIGURE 25 DEVELOPING COUNTRIES TO OFFER GROWTH OPPORTUNITIES TO MARKET PLAYERS DURING FORECAST PERIOD 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 63
FIGURE 26 ANIMAL PARASITICIDES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 63
5.2.1 DRIVERS 64
5.2.1.1 Rising demand for animal-derived food products 64
FIGURE 27 WORLD MILK PRODUCTION ESTIMATES (2021–2030) 64
FIGURE 28 WORLD MEAT PRODUCTION ESTIMATES (2021–2030) 65
5.2.1.2 Increasing investments by private players 65
5.2.1.3 Growing concerns of zoonotic diseases 65
5.2.1.4 Regulations for preventing spread of animal diseases 66
5.2.1.5 Growing companion animal ownership rates 66
FIGURE 29 EUROPE: PET POPULATION 67
5.2.1.6 Growing prevalence of animal diseases 67
5.2.1.7 Rising animal health expenditure 68
FIGURE 30 US: INCREASING PET EXPENDITURE, 2010–2021 (USD BILLION) 68
FIGURE 31 EUROPE: ANNUAL VALUE OF PET-RELATED PRODUCTS, 2010–2021 (EUR BILLION) 68
5.2.2 RESTRAINTS 69
5.2.2.1 Regulations restricting use of parasiticides for food-producing animals 69
5.2.2.2 Shift toward vegetarianism 69
5.2.2.3 Novel drug development models 70
5.2.3 OPPORTUNITIES 70
5.2.3.1 Lucrative growth opportunities in emerging markets 70
5.2.4 CHALLENGES 71
5.2.4.1 Growing resistance to parasiticides 71
TABLE 1 PARASITICIDES AND RESISTANT PARASITES 71
5.2.4.2 Stringent regulatory approval process for drugs 71
5.2.4.3 Diversity in parasite species 72
5.3 PRICING ANALYSIS 72
5.3.1 AVERAGE SELLING PRICE OF ANIMAL PARASITICIDES, BY TYPE 72
TABLE 2 AVERAGE SELLING PRICE OF ANIMAL PARASITICIDES, BY TYPE (USD) 72
5.3.2 AVERAGE SELLING PRICE TRENDS 72
5.4 SUPPLY CHAIN ANALYSIS 73
FIGURE 32 SUPPLY CHAIN ANALYSIS: ANIMAL PARASITICIDES MARKET 74
5.5 ECOSYSTEM ANALYSIS 74
FIGURE 33 ECOSYSTEM ANALYSIS: ANIMAL PARASITICIDES MARKET 75
5.6 PATENT ANALYSIS 75
FIGURE 34 PATENT PUBLICATION TRENDS (JANUARY 2013–FEBRUARY 2023) 75
5.6.1 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR ANIMAL PARASITICIDES 76
FIGURE 35 TOP APPLICANTS (COMPANIES/INSTITUTES) FOR ANIMAL PARASITICIDE PATENTS (2013–2023) 76
5.7 VALUE CHAIN ANALYSIS 76
FIGURE 36 VALUE CHAIN ANALYSIS: ANIMAL PARASITICIDES MARKET 77
5.8 CASE STUDIES 78
FIGURE 37 CASE STUDY: MARKET ASSESSMENT FOR COMPANION ANIMALS 78
FIGURE 38 CASE STUDY: OPPORTUNITY ANALYSIS FOR BROAD-SPECTRUM PARASITICIDES 79
5.9 REGULATORY ANALYSIS 79
5.9.1 REGULATORY LANDSCAPE 79
TABLE 3 US: RECENT DEVELOPMENTS IN REGULATIONS FOR VETERINARY DRUGS 81
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
5.9.2.1 North America 82
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
5.9.2.2 Europe 84
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
5.9.2.3 Asia Pacific and Rest of the World 85
TABLE 6 ASIA PACIFIC AND REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
5.10 PORTER’S FIVE FORCES ANALYSIS 85
TABLE 7 PORTER’S FIVE FORCES ANALYSIS: ANIMAL PARASITICIDES MARKET (2021) 85
5.10.1 INTENSITY OF COMPETITIVE RIVALRY 86
5.10.2 BARGAINING POWER OF SUPPLIERS 86
5.10.3 BARGAINING POWER OF BUYERS 86
5.10.4 THREAT OF NEW ENTRANTS 86
5.10.5 THREAT OF SUBSTITUTES 87
5.11 ADJACENT MARKET ANALYSIS 87
FIGURE 39 ANIMAL ANTIBIOTICS AND ANTIMICROBIALS MARKET: MARKET OVERVIEW 88
5.12 KEY CONFERENCES AND EVENTS DURING 2023–2024 88
TABLE 8 ANIMAL PARASITICIDES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 88
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 89
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 89
FIGURE 40 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF ANIMAL PARASITICIDES 89
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES OF ANIMAL PARASITICIDES 90
5.13.2 BUYING CRITERIA 90
TABLE 10 KEY BUYING CRITERIA FOR TOP THREE TYPES OF ANIMAL PARASITICIDES 90
5.14 TRADE ANALYSIS 91
5.15 INDUSTRY TRENDS 91
5.15.1 GROWING CONSOLIDATION IN ANIMAL HEALTH INDUSTRY 91
TABLE 11 MAJOR ACQUISITIONS IN ANIMAL PARASITICIDES INDUSTRY (2019–2021) 91
5.15.2 INNOVATIONS IN ANIMAL PARASITICIDES 92
TABLE 12 INNOVATIVE ANIMAL PHARMACEUTICAL TRENDS 92
5.16 IMPACT OF INFLATION AND RECESSION ON ANIMAL PARASITICIDES MARKET 93
6 ANIMAL PARASITICIDES MARKET, BY TYPE 94
6.1 INTRODUCTION 95
TABLE 13 ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 95
TABLE 14 ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
6.2 ECTOPARASITICIDES 96
TABLE 15 EXAMPLES OF ECTOPARASITICIDES AVAILABLE IN MARKET 97
TABLE 16 ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 98
TABLE 17 ECTOPARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98
6.2.1 POUR-ONS & SPOT-ONS 99
6.2.1.1 Ease of application to support adoption 99
TABLE 18 POUR-ONS & SPOT-ONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
6.2.2 ORAL TABLETS 100
6.2.2.1 High medication compliance and ease of administration to drive market 100
TABLE 19 ORAL TABLETS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
6.2.3 SPRAYS 101
6.2.3.1 Low price and convenience to drive market 101
TABLE 20 SPRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
6.2.4 DIPS 102
6.2.4.1 High popularity ensured sustained end-user demand 102
TABLE 21 DIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 102
6.2.5 EAR TAGS 103
6.2.5.1 Highly effective in controlling flies around cattle 103
TABLE 22 EAR TAGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 103
6.2.6 COLLARS 104
6.2.6.1 Growing prevalence of infections in companion animals to drive adoption 104
TABLE 23 COLLARS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 104
6.2.7 OTHER ECTOPARASITICIDES 105
TABLE 24 OTHER ECTOPARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 105
6.3 ENDOPARASITICIDES 106
TABLE 25 EXAMPLES OF ENDOPARASITICIDES AVAILABLE IN MARKET 106
TABLE 26 ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 107
TABLE 27 ENDOPARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 107
6.3.1 ORAL LIQUIDS 108
6.3.1.1 Growing demand for meat and milk products to drive market 108
TABLE 28 ORAL LIQUIDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 108
6.3.2 ORAL SOLIDS 109
6.3.2.1 Emergence of internal parasitic infections in dogs to drive market 109
TABLE 29 ORAL SOLIDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 109
6.3.3 INJECTABLES 110
6.3.3.1 Mostly used in food-producing animals 110
TABLE 30 INJECTABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 110
6.3.4 FEED ADDITIVES 111
6.3.4.1 Can be administered to large number of animals at once 111
TABLE 31 FEED ADDITIVES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111
6.3.5 OTHER ENDOPARASITICIDES 112
TABLE 32 OTHER ENDOPARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 112
6.4 ENDECTOCIDES 112
6.4.1 POTENTIAL TO TREAT BOTH INTERNAL AND EXTERNAL PARASITE INFECTIONS 112
TABLE 33 EXAMPLES OF ENDECTOCIDES AVAILABLE IN MARKET 113
TABLE 34 ENDECTOCIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 114
7 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE 115
7.1 INTRODUCTION 116
TABLE 35 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 116
7.2 COMPANION ANIMALS 116
TABLE 36 COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 116
TABLE 37 COMPANION ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 117
7.2.1 DOGS 117
7.2.1.1 Most adopted companion animals 117
TABLE 38 COMPANION ANIMAL PARASITICIDES MARKET FOR DOGS, BY COUNTRY, 2020–2027 (USD MILLION) 118
7.2.2 CATS 118
7.2.2.1 High vulnerability to parasitic infections to support market growth 118
TABLE 39 COMPANION ANIMAL PARASITICIDES MARKET FOR CATS, BY COUNTRY, 2020–2027 (USD MILLION) 119
7.2.3 HORSES 119
7.2.3.1 Rising need for equine parasitic control to drive market 119
TABLE 40 HORSE POPULATION, BY REGION, 2016–2019 (MILLION) 120
TABLE 41 COMPANION ANIMAL PARASITICIDES MARKET FOR HORSES, BY COUNTRY, 2020–2027 (USD MILLION) 120
7.2.4 OTHER COMPANION ANIMALS 121
TABLE 42 OTHER COMPANION ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 121
7.3 LIVESTOCK 122
FIGURE 41 PRODUCTION OF MEAT WORLDWIDE, BY TYPE, 2016–2020 122
TABLE 43 LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 122
TABLE 44 LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
7.3.1 CATTLE 123
7.3.1.1 Susceptible to parasitic infestations and diseases due to internal parasites 123
TABLE 45 LIVESTOCK PARASITICIDES MARKET FOR CATTLE, BY COUNTRY, 2020–2027 (USD MILLION) 124
7.3.2 PIGS 124
7.3.2.1 Growing pork consumption to drive demand for parasiticides 124
TABLE 46 LIVESTOCK PARASITICIDES MARKET FOR PIGS, BY COUNTRY, 2020–2027 (USD MILLION) 125
7.3.3 POULTRY 125
7.3.3.1 Growing egg consumption in emerging countries to drive demand for parasiticides 125
FIGURE 42 LEADING EGG-PRODUCING COUNTRIES WORLDWIDE, 2019 126
TABLE 47 LIVESTOCK PARASITICIDES MARKET FOR POULTRY, BY COUNTRY, 2020–2027 (USD MILLION) 126
7.3.4 SHEEP & GOATS 127
7.3.4.1 Growth in consumption of sheep and goat meat to drive market 127
TABLE 48 LIVESTOCK PARASITICIDES MARKET FOR SHEEP & GOATS, BY COUNTRY, 2020–2027 (USD MILLION) 127
7.3.5 OTHER LIVESTOCK 128
TABLE 49 OTHER LIVESTOCK PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 128
8 ANIMAL PARASITICIDES MARKET, BY END USER 129
8.1 INTRODUCTION 130
TABLE 50 ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 130
8.2 VETERINARY HOSPITALS AND CLINICS 130
8.2.1 HIGH ADOPTION OF ANIMAL PARASITICIDES IN VETERINARY HOSPITALS AND CLINICS TO DRIVE MARKET 130
TABLE 51 ANIMAL PARASITICIDES MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 131
8.3 ANIMAL FARMS 131
8.3.1 INCREASING INCIDENCE OF PARASITIC INFECTIONS IN LIVESTOCK TO SUPPORT MARKET GROWTH 131
TABLE 52 ANIMAL PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY, 2020–2027 (USD MILLION) 132
8.4 HOME CARE SETTINGS 132
8.4.1 RISING PET OWNERSHIP AND AWARENESS TO DRIVE MARKET 132
TABLE 53 ANIMAL PARASITICIDES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2020–2027 (USD MILLION) 133
9 ANIMAL PARASITICIDES MARKET, BY REGION 134
9.1 INTRODUCTION 135
FIGURE 43 ANIMAL PARASITICIDES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 135
TABLE 54 ANIMAL PARASITICIDES MARKET, BY REGION, 2020–2027 (USD MILLION) 136
9.2 NORTH AMERICA 136
FIGURE 44 NORTH AMERICA: ANIMAL PARASITICIDES MARKET SNAPSHOT 137
9.2.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN NORTH AMERICA 137
TABLE 55 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 138
TABLE 56 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 57 NORTH AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 58 NORTH AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 59 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 139
TABLE 60 NORTH AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 139
TABLE 61 NORTH AMERICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 140
TABLE 62 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 140
9.2.2 US 140
9.2.2.1 Rising pet expenditure and increasing meat consumption to drive market 140
FIGURE 45 US: PET ADOPTION DURING COVID-19 PANDEMIC 141
FIGURE 46 US: INCREASE IN PET EXPENDITURE, 2011–2021 (USD BILLION) 141
FIGURE 47 US: BEEF CONSUMPTION, 2011–2021 (BILLION POUNDS) 142
TABLE 63 US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2018 VS. 2019 VS. 2020 142
TABLE 64 US: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 65 US: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 66 US: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 67 US: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 144
TABLE 68 US: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 144
TABLE 69 US: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 145
TABLE 70 US: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 145
9.2.3 CANADA 145
9.2.3.1 Growing pet adoption to support market growth 145
TABLE 71 CANADA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 72 CANADA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 73 CANADA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 74 CANADA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 147
TABLE 75 CANADA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 147
TABLE 76 CANADA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 148
TABLE 77 CANADA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 148
9.3 EUROPE 148
TABLE 78 EUROPE: LIVESTOCK POPULATION, BY TYPE, 2011–2021 (MILLION) 149
9.3.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN EUROPE 149
TABLE 79 EUROPE: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 80 EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 81 EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 82 EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 83 EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 151
TABLE 84 EUROPE: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 152
TABLE 85 EUROPE: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 152
TABLE 86 EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 152
9.3.2 GERMANY 153
9.3.2.1 Growing demand for quality animal-derived food products to drive market 153
TABLE 87 GERMANY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 88 GERMANY: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 89 GERMANY: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 90 GERMANY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 154
TABLE 91 GERMANY: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 155
TABLE 92 GERMANY: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 155
TABLE 93 GERMANY: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 155
9.3.3 UK 156
9.3.3.1 Increasing pet ownership to drive market 156
TABLE 94 UK: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 95 UK: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 96 UK: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 97 UK: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 157
TABLE 98 UK: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 158
TABLE 99 UK: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 158
TABLE 100 UK: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 158
9.3.4 FRANCE 159
9.3.4.1 Presence of major market players to propel market growth 159
TABLE 101 FRANCE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 102 FRANCE: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 103 FRANCE: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 104 FRANCE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 160
TABLE 105 FRANCE: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 161
TABLE 106 FRANCE: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 161
TABLE 107 FRANCE: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 161
9.3.5 SPAIN 162
9.3.5.1 Increasing animal health expenditure to drive market 162
TABLE 108 SPAIN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 109 SPAIN: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 110 SPAIN: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 163
TABLE 111 SPAIN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 163
TABLE 112 SPAIN: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 164
TABLE 113 SPAIN: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 164
TABLE 114 SPAIN: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 164
9.3.6 ITALY 165
9.3.6.1 Need to curb zoonotic diseases in livestock to propel market 165
TABLE 115 ITALY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 116 ITALY: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 117 ITALY: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 118 ITALY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 166
TABLE 119 ITALY: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 167
TABLE 120 ITALY: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 167
TABLE 121 ITALY: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 167
9.3.7 REST OF EUROPE 168
FIGURE 48 NETHERLANDS: NUMBER OF DAIRY COWS, 2011–2020 (THOUSAND) 168
TABLE 122 REST OF EUROPE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2021 (MILLION) 168
TABLE 123 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 124 REST OF EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 125 REST OF EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 126 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 170
TABLE 127 REST OF EUROPE: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 170
TABLE 128 REST OF EUROPE: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 170
TABLE 129 REST OF EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 171
9.4 ASIA PACIFIC 171
FIGURE 49 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET SNAPSHOT 172
9.4.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN ASIA PACIFIC 172
TABLE 130 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 173
TABLE 131 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 132 ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 133 ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 134 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 174
TABLE 135 ASIA PACIFIC: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 175
TABLE 136 ASIA PACIFIC: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 175
TABLE 137 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 175
9.4.2 CHINA 176
9.4.2.1 Increasing pet expenditure and companion animal ownership to propel market 176
FIGURE 50 CHINA: CONSUMPTION OF PORK PRODUCTS PER CAPITA, 2011–2021 (KILOGRAMS) 176
TABLE 138 CHINA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 139 CHINA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 140 CHINA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 141 CHINA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 178
TABLE 142 CHINA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 178
TABLE 143 CHINA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 178
TABLE 144 CHINA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 179
9.4.3 AUSTRALIA & NEW ZEALAND 179
9.4.3.1 Rising livestock population and increasing awareness about parasitic infections to drive market 179
TABLE 145 AUSTRALIA & NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 146 AUSTRALIA & NEW ZEALAND: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 147 AUSTRALIA & NEW ZEALAND: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 148 AUSTRALIA & NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 181
TABLE 149 AUSTRALIA & NEW ZEALAND: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 181
TABLE 150 AUSTRALIA & NEW ZEALAND: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 182
TABLE 151 AUSTRALIA & NEW ZEALAND: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 182
9.4.4 JAPAN 182
9.4.4.1 Rising pet care expenditure to propel market 182
TABLE 152 JAPAN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 153 JAPAN: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 154 JAPAN: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 184
TABLE 155 JAPAN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 184
TABLE 156 JAPAN: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 184
TABLE 157 JAPAN: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 185
TABLE 158 JAPAN: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 185
9.4.5 INDIA 185
9.4.5.1 Rising demand for animal-derived food products to support market growth 185
TABLE 159 INDIA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 160 INDIA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 161 INDIA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 162 INDIA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 187
TABLE 163 INDIA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 188
TABLE 164 INDIA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 188
TABLE 165 INDIA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 188
9.4.6 SOUTH KOREA 189
9.4.6.1 Rising investments in animal healthcare infrastructure to propel market 189
TABLE 166 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 167 SOUTH KOREA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 190
TABLE 168 SOUTH KOREA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 190
TABLE 169 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 190
TABLE 170 SOUTH KOREA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 191
TABLE 171 SOUTH KOREA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 191
TABLE 172 SOUTH KOREA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 191
9.4.7 REST OF ASIA PACIFIC 192
TABLE 173 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 174 REST OF ASIA PACIFIC: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 175 REST OF ASIA PACIFIC: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 176 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 193
TABLE 177 REST OF ASIA PACIFIC: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 193
TABLE 178 REST OF ASIA PACIFIC: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 194
TABLE 179 REST OF ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 194
9.5 LATIN AMERICA 194
9.5.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN LATIN AMERICA 195
TABLE 180 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 195
TABLE 181 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 182 LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 183 LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 184 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 196
TABLE 185 LATIN AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 197
TABLE 186 LATIN AMERICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 197
TABLE 187 LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 197
9.5.2 BRAZIL 198
9.5.2.1 Growing prevalence of zoonotic diseases to drive market 198
TABLE 188 BRAZIL: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 198
TABLE 189 BRAZIL: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 190 BRAZIL: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 199
TABLE 191 BRAZIL: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 199
TABLE 192 BRAZIL: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 200
TABLE 193 BRAZIL: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 200
TABLE 194 BRAZIL: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 200
9.5.3 REST OF LATIN AMERICA 201
TABLE 195 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 196 REST OF LATIN AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 197 REST OF LATIN AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 202
TABLE 198 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 202
TABLE 199 REST OF LATIN AMERICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 202
TABLE 200 REST OF LATIN AMERICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 203
TABLE 201 REST OF LATIN AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 203
9.6 MIDDLE EAST AND AFRICA 203
9.6.1 IMPACT OF RECESSION ON ANIMAL PARASITICIDES MARKET IN MIDDLE EAST AND AFRICA 203
TABLE 202 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 204
TABLE 203 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 204
TABLE 204 MIDDLE EAST AND AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 205 MIDDLE EAST AND AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 205
TABLE 206 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 206
TABLE 207 MIDDLE EAST AND AFRICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 206
TABLE 208 MIDDLE EAST AND AFRICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 206
TABLE 209 MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 207
9.6.2 TURKEY 207
9.6.2.1 Increase in companion animal population to drive market 207
TABLE 210 TURKEY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 207
TABLE 211 TURKEY: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 212 TURKEY: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 208
TABLE 213 TURKEY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 208
TABLE 214 TURKEY: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 209
TABLE 215 TURKEY: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 209
TABLE 216 TURKEY: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 209
9.6.3 REST OF MIDDLE EAST AND AFRICA 210
TABLE 217 REST OF MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 218 REST OF MIDDLE EAST AND AFRICA: ECTOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 210
TABLE 219 REST OF MIDDLE EAST AND AFRICA: ENDOPARASITICIDES MARKET, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 220 REST OF MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 211
TABLE 221 REST OF MIDDLE EAST AND AFRICA: COMPANION ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 211
TABLE 222 REST OF MIDDLE EAST AND AFRICA: LIVESTOCK PARASITICIDES MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 212
TABLE 223 REST OF MIDDLE EAST AND AFRICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2020–2027 (USD MILLION) 212
10 COMPETITIVE LANDSCAPE 213
10.1 OVERVIEW 213
10.2 KEY PLAYER STRATEGIES 213
FIGURE 51 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN ANIMAL PARASITICIDES MARKET 214
10.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN ANIMAL PARASITICIDES MARKET 214
FIGURE 52 REVENUE ANALYSIS FOR KEY PLAYERS IN ANIMAL PARASITICIDES MARKET 215
10.4 MARKET SHARE ANALYSIS 215
FIGURE 53 ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021 216
TABLE 224 ANIMAL PARASITICIDES MARKET: DEGREE OF COMPETITION 217
10.5 R&D ASSESSMENT OF KEY PLAYERS 218
10.6 COMPANY EVALUATION QUADRANT 218
FIGURE 54 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX, 2021 219
10.6.1 STARS 220
10.6.2 PERVASIVE PLAYERS 220
10.6.3 EMERGING LEADERS 220
10.6.4 PARTICIPANTS 220
10.7 COMPETITIVE LEADERSHIP MAPPING FOR SMES AND STARTUPS 221
FIGURE 55 ANIMAL PARASITICIDES MARKET: COMPANY EVALUATION MATRIX FOR SMES AND STARTUPS, 2021 221
10.7.1 PROGRESSIVE COMPANIES 222
10.7.2 DYNAMIC COMPANIES 222
10.7.3 STARTING BLOCKS 222
10.7.4 RESPONSIVE COMPANIES 222
10.8 COMPETITIVE BENCHMARKING 223
10.8.1 OVERALL COMPANY FOOTPRINT 223
TABLE 225 OVERALL COMPANY FOOTPRINT 223
TABLE 226 COMPANY FOOTPRINT ANALYSIS, BY TYPE 224
TABLE 227 COMPANY FOOTPRINT ANALYSIS, BY ANIMAL TYPE 225
TABLE 228 COMPANY FOOTPRINT ANALYSIS, BY END USER 226
TABLE 229 COMPANY FOOTPRINT ANALYSIS, BY REGION 227
10.9 COMPETITIVE SCENARIO 228
10.9.1 PRODUCT LAUNCHES AND APPROVALS 228
TABLE 230 PRODUCT LAUNCHES AND APPROVALS, JANUARY 2019–FEBRUARY 2023 228
10.9.2 DEALS 229
TABLE 231 DEALS, JANUARY 2019–FEBRUARY 2023 229
10.9.3 OTHER DEVELOPMENTS 231
TABLE 232 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2023 231
11 COMPANY PROFILES 232
11.1 KEY PLAYERS 232
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 BOEHRINGER INGELHEIM GMBH 232
TABLE 233 BOEHRINGER INGELHEIM GMBH: BUSINESS OVERVIEW 232
FIGURE 56 BOEHRINGER INGELHEIM GMBH: COMPANY SNAPSHOT (2021) 233
11.1.2 ZOETIS INC. 236
TABLE 234 ZOETIS INC.: BUSINESS OVERVIEW 236
FIGURE 57 ZOETIS INC.: COMPANY SNAPSHOT (2021) 237
11.1.3 ELANCO ANIMAL HEALTH INCORPORATED 240
TABLE 235 ELANCO ANIMAL HEALTH INCORPORATED: BUSINESS OVERVIEW 240
FIGURE 58 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2021) 241
11.1.4 MERCK & CO., INC 245
TABLE 236 MERCK & CO., INC.: BUSINESS OVERVIEW 245
FIGURE 59 MERCK & CO., INC.: COMPANY SNAPSHOT (2021) 246
11.1.5 VIRBAC 249
TABLE 237 VIRBAC: BUSINESS OVERVIEW 249
FIGURE 60 VIRBAC: COMPANY SNAPSHOT (2021) 250
11.1.6 VETOQUINOL S.A. 253
TABLE 238 VETOQUINOL S.A.: BUSINESS OVERVIEW 253
FIGURE 61 VETOQUINOL S.A.: COMPANY SNAPSHOT (2021) 253
11.1.7 PETIQ, LLC 255
TABLE 239 PETIQ, LLC: BUSINESS OVERVIEW 255
FIGURE 62 PETIQ, LLC: COMPANY SNAPSHOT (2021) 256
11.1.8 SEQUENT SCIENTIFIC LIMITED 258
TABLE 240 SEQUENT SCIENTIFIC LIMITED: BUSINESS OVERVIEW 258
FIGURE 63 SEQUENT SCIENTIFIC LIMITED: COMPANY SNAPSHOT (2021) 259
11.1.9 KRKA GROUP 261
TABLE 241 KRKA GROUP: BUSINESS OVERVIEW 261
FIGURE 64 KRKA GROUP: COMPANY SNAPSHOT (2021) 262
11.1.10 ECO ANIMAL HEALTH GROUP PLC 264
TABLE 242 ECO ANIMAL HEALTH GROUP PLC: BUSINESS OVERVIEW 264
FIGURE 65 ECO ANIMAL HEALTH GROUP PLC: COMPANY SNAPSHOT (2021) 264
11.2 OTHER PLAYERS 266
11.2.1 CEVA SANTÉ ANIMALE 266
TABLE 243 CEVA SANTÉ ANIMALE: BUSINESS OVERVIEW 266
11.2.2 CHANELLE PHARMA 268
TABLE 244 CHANELLE PHARMA: BUSINESS OVERVIEW 268
11.2.3 BIMEDA ANIMAL HEALTH 269
TABLE 245 BIMEDA ANIMAL HEALTH: BUSINESS OVERVIEW 269
11.2.4 NORBROOK 271
TABLE 246 NORBROOK: BUSINESS OVERVIEW 271
11.2.5 KYORITSU SEIYAKU CORPORATION 272
TABLE 247 KYORITSU SEIYAKU CORPORATION: BUSINESS OVERVIEW 272
11.2.6 SMARTVET HOLDINGS, INC. 274
TABLE 248 SMARTVET HOLDINGS, INC.: BUSINESS OVERVIEW 274
11.2.7 UCBVET 275
TABLE 249 UCBVET: BUSINESS OVERVIEW 275
11.2.8 CALIER 276
TABLE 250 CALIER: BUSINESS OVERVIEW 276
11.2.9 ABBEY ANIMAL HEALTH PTY LTD. 277
TABLE 251 ABBEY ANIMAL HEALTH PTY LTD.: BUSINESS OVERVIEW 277
11.2.10 BIOGÉNESIS BAGÓ 278
TABLE 252 BIOGÉNESIS BAGÓ: BUSINESS OVERVIEW 278
11.2.11 PRN PHARMACAL 280
TABLE 253 PRN PHARMACAL: BUSINESS OVERVIEW 280
11.2.12 LUTIM PHARMA PRIVATE LIMITED 281
TABLE 254 LUTIM PHARMA PRIVATE LIMITED: BUSINESS OVERVIEW 281
11.2.13 VETANCO SA 282
TABLE 255 VETANCO SA: BUSINESS OVERVIEW 282
11.2.14 BRILLIANT BIO PHARMA 283
TABLE 256 BRILLIANT BIO PHARMA: BUSINESS OVERVIEW 283
11.2.15 ZUCHE PHARMACEUTICALS PVT. LTD. 284
TABLE 257 ZUCHE PHARMACEUTICALS PVT. LTD.: BUSINESS OVERVIEW 284
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 285
12.1 DISCUSSION GUIDE 285
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 291
12.3 CUSTOMIZATION OPTIONS 293
12.4 RELATED REPORTS 294
12.5 AUTHOR DETAILS 295